Department of Internal Medicine, Greater Baltimore Medical Center, Baltimore, MD, United States.
Curr Opin Pharmacol. 2011 Dec;11(6):612-6. doi: 10.1016/j.coph.2011.09.006. Epub 2011 Oct 10.
MicroRNAs (miRs) have recently emerged as a novel class of gene expression regulators. The number of studies documenting an altered miR expression pattern in cancer continues to expand rapidly. Critical information is continuously gained regarding how aberrantly expressed miRs contribute to carcinogenesis. Current studies provide evidence that analyses of miR expression patterns have potential clinical applications toward developing tumor biomarkers to identify the presence and dissemination of esophageal cancer, as well as to assess tumor chemosensitivity or radiosensitivity. The incidence of esophageal cancer is on the rise, and this disease continues to portend a poor prognosis. The current review addresses ways in which altered miR expression contributes to esophageal carcinogenesis, along with how recent discoveries may be applied clinically.
MicroRNAs (miRs) 最近作为一类新的基因表达调控因子出现。越来越多的研究记录了癌症中 miR 表达模式的改变。不断获得关于异常表达的 miR 如何促进癌变的关键信息。目前的研究提供了证据,表明 miR 表达模式分析具有潜在的临床应用价值,可以开发肿瘤生物标志物来识别食管癌的存在和传播,并评估肿瘤的化疗敏感性或放射敏感性。食管癌的发病率正在上升,这种疾病仍然预示着预后不良。本综述讨论了改变的 miR 表达如何促进食管癌的发生,以及最近的发现如何在临床上应用。